Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
96.52
+0.03 (0.03%)
Apr 14, 2026, 9:30 AM EDT - Market open
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $5.82 billion as of April 14, 2026. Its market cap has increased by 157.87% in one year.
Market Cap
5.82B
Enterprise Value
5.76B
1-Year Change
157.87%
Ranking
Category
Stock Price
$96.52
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $5.82B, an increase of 1,859.50%. That is a compound annual growth rate of 55.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 5.82B | 42.62% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 6.31B |
| Centessa Pharmaceuticals | 6.11B |
| Terns Pharmaceuticals | 6.08B |
| Cogent Biosciences | 5.86B |
| Rhythm Pharmaceuticals | 5.76B |
| Scholar Rock Holding | 5.74B |
| CG Oncology | 5.72B |
| PTC Therapeutics | 5.69B |